Identification of a novel GREMLIN1 uptake pathway in epithelial cells that requires BMP binding
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.110780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Zhichun Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, No…. Hauptthemen laut MEDLINE: Intercellular Signaling Peptides and Proteins, Epithelial Cells, Endocytosis, Bone Morphogenetic Protein 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department for the Economy, Queen's University Belfast, UK Research and Innovation Medical Research Council.
Abstract (Originalsprache)
GREM1 binding to BMP targets in the extracellular matrix prevents their engagement with cognate BMP receptors, attenuating BMP-dependent signaling and gene expression. Some evidence suggests that GREM1 can directly bind to receptor tyrosine kinases on the plasma membrane, further complicating our understanding of GREM1 biology. To attempt to clarify the complexities of GREM1 signaling, we show that GREM1 protein is produced and secreted by intestinal fibroblasts and endocytosed by neighboring epithelial cells. GREM1 uptake occurs by both clathrin- and caveolin-mediated endocytosis. Cell membrane heparin sulfate proteoglycans are required for GREM1 binding and uptake, and once internalized, GREM1 appears to localize to the early endosomes and can be resecreted. The addition of BMP2 enhanced GREM1 uptake into cells. Remarkably, the generation of a BMP-resistant GREM1 mutant abolished GREM1 uptake both in the presence and in the absence of BMP2. These data suggest that GREM1 binding and uptake into cells requires BMP binding, a process that may contribute to the antagonism of BMP signaling by GREM1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland, UK.
- Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, Scotland, UK.
- Cardiovascular Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Patrick G. Johnston Center for Cancer Research, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland, UK.
- Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland, UK. Electronic address: d.brazil@qub.ac.uk.
Förderung
- Department for the Economy
- Queen's University Belfast
- UK Research and Innovation Medical Research Council
Zitieren
APA
Gao, Z., Gao, Y., Dutton, L. R., Suner, M. B., Todd, G., Gipson, G. R., Brown, C., Kerr, E. M., Daly, C., Plouffe, B., Dunne, P. D., Malinova, D., & Brazil, D. P. (2025). Identification of a novel GREMLIN1 uptake pathway in epithelial cells that requires BMP binding. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110780
Vancouver
Gao Z, Gao Y, Dutton LR, Suner MB, Todd G, Gipson GR, et al. Identification of a novel GREMLIN1 uptake pathway in epithelial cells that requires BMP binding. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110780
BibTeX
@article{Gao2025,
author = {Gao, Zhichun and Gao, Yuhan and Dutton, Louise R and Suner, Melibea Berzosa and Todd, Grace and Gipson, Gregory R and Brown, Connor and Kerr, Emma M and Daly, Carole and Plouffe, Bianca and Dunne, Philip D and Malinova, Dessislava and Brazil, Derek P},
title = {Identification of a novel GREMLIN1 uptake pathway in epithelial cells that requires BMP binding},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.110780}
}
EUVIMED